Udział zapalenia starczego w procesie onkogenezy

• Autorzy: Madej J.A.

Warianty tytułu

EN

Influence of inflammaging on oncogenesis

• Języki publikacji: PL

Abstrakty

EN

There is a specific antagonism between an aging organism and neoplasia, in which the tumor is considered to influence the local tissue. It returns to some atavistic features, including the thermodynamic approach (2nd law of thermodynamics, Fig. 1), causing the rejuvenation of the surrounding tissue. The existence of various theories of oncogenesis entitles their supplementation with the theory of inflammaging: an entropic inflammation that can potentially have an indirect influence on the oncogenesis. This theory covers the effects of various causes of aging, including genetically programmed changes, telomere dependent processes and damage of genome, epigenome and proteome particles. The paper describes the patomechanism of inflammaging, including the role of mitochondria (point mutations and deletions especially in mtDNA), oxidative stress with overproduction and accumulation of free radicals and NFkB factor (nuclear factor kappa-light chain-enhancer of activated B cells) and the possibility of the influence of inflammaging on oncogenesis (Fig. 2). The inflamma-ging is programmed by hypothalamus using the immune-neuro-endocrine system, including gonadotropin releasing hormone (GnRH) that inhibits the NFkB factor with the inactivation of kinase IKK-beta. Regardless of that, the chronic inflammation, exceeding its defensive competence, lasts for years and can also be the beginning of neoplastic cells proliferation.

Słowa kluczowe

PL

starzenie sie zwierzat; onkogeneza; zapalenie starcze; nowotwory; nowotworzenie

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2019
• Tom: 75
• Numer: 02
• Opis fizyczny: s.78-87,rys.,bibliogr.

Twórcy

autor

Madej J.A.

• Zakład Patomorfologii i Weterynarii Sądowej, Katedra Patologii, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy we Wrocławiu, ul.Norwida 29, 50-375 Wrocław

Bibliografia

• Alster A., Korwek Z.: Znaczniki starzenia komórkowego. Post. Biochem. 2014, 60, 138-146.
• Balińska M., Brzezińska W., Wińska P.: Nowotwory a starzenie. Post. Biol. Kom. 2000, supl. 15, 27-45.
• Bollarath J., Greten F. R.: IKK/NF-kappaB and STAT3 pathways: central signaling hubs in inflammation-mediated tumour promootionand metastasis. EMBO Rep. 2009, 10, 1314-1319.
• Bonafe M., Storei G., Franceschi G.: Inflammaging of the stem cell niche: brest cancer as a paradigmatic example: brakdown of the multishell cytokine network fuels cancer in aged people. Bioessays 2012, 49, 34-40.
• Dall`Olio F., Vanhooren V., Chen C. C., Slagboom P. E., Wuhrwe M., Franceschi G.: N-glycomic biomarkers of biological aging and longevity: a link with inflammaging. Ageing Res. Rev. 2013, 12, 685-698.
• Franceschi G.: Infalmmaging as a major characteristic of old people: can it be prevented or cured? Nutr. Rev. 2007, 65, 173-176.
• Franceschi G., Bonafe M., Valensisn S.: Inflammaging. An evolutionary perspective on immunoscenescence. Ann. N.Y. Acad. Sci 2000, 908, 244-245.
• Franceschi C., Campisi J.: Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A. Sci. Med. Biol. Sci. 2014, 69, 94-101.
• Friedman J. R., Nunnari J.: Mitochondrial form and function (review). Nature 2014, 505, 335-343.
• Fuller G. M., Shields D.: Podstawy molekularne biologii komórki. Aspekty Medyczne. PZWL, Warszawa 2000.
• Gallenga C. E., Parmeggiani F., Costagliola C., Sebastini A., Gallenga P. T.: Inflammaging: should this term be suitable for age related macular degeneration too? Inflamm. Rev. 2014, 63, 105-107.
• Gołąb J., Jakóbisiak M., Lasek W., Stokłosa T. (pod red.).: Immunologia. PWN, Warszawa 2007.
• Handschin C., Spiegelman B. M.: The role of exercise and PGC1 alpha in inflammation and chronic disease. Nature 2008, 454, 463-469.
• Holliday R.: Understanding ageing. Cambridge Univ. Press, Cambridge 1995.
• Iyer S. S., He Q., Janczy J. R.: Mitochondrial cardiolipin is requiret for Nlrp3 inflam-masome activation. Immunity 2013, 39, 311-323.
• Kawiak J., Zabel M.: Seminaria z cytofizjologii. Wyd. 2, Elsevier Urban & Partner, Wrocław 2014.
• Kumar V., Cotran R. S., Robbins S. L.: Robbins Patologia. Elsevier Urban & Partner, Wrocław 2007.
• Madej J. A.: Etiologia i patogeneza nowotworów. alfa-Medica Press, wyd. II, Bielsko-Biała 1999.
• Madej J. A.: Podstawy cytopatologii. Wyd. Med. Urban & Partner, Wrocław 2003.
• Madej J. A.: Progerias and anticipative diseases. Med. Weter. 2012, 68, 67-73.
• Madej J. A.: Zapalenie – przekroczenie kompetencji obronnych. Med. Weter. 2010, 66, 156-161.
• Maumbres C., Barbacid M.: Cell cycke, CDK and cancer a changing paradigm. Nature Rev. Cancer 2009, 9, 153-160.
• Owczarek T. B., Suchański J., Pula B., Kmiecik A. M., Chadalski M., Jethon A., Dzięgiel P., Ugorski M.: Galactosylceramide affects tumorigenic and metastatic propierties of breast cancer cells as an anti-apoptotic molecule. Plos One. 2013, 8, 84-91.
• Ridley M.: The cooperative gene. How Mendel’s demon explains to beings. New York, The Free Press 2010.
• Russel O., Turbull D.: Mitochondrial DNA disease – molecular insights and potential routes to a curs. Exp. Cell Res. 2014, 325, 38-43.
• Sahin E., DePinho R. A.: Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 210, 464, 520-528.
• Sepulveda A. R.: Molecular testing of Helicobacter pylori-associated chronic gastritis and premalignant gastric lesions: clinical implications. J. Clin. Gastroenterol. 2001, 32, 377-381.
• Silbernagl S., Lange F.: Atlas patofizjologii. MedPharm Polska, Wrocław 2011.
• Tchkonia T., Zhu Y., van Deursen J., Campisi J., Kirkland J. L.: Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Invest. 2013, 123, 966-972.
• Tilly H., Dreyling M.: Diffuse large B-cell non-Hodgkin’s lymphoma: ESMO Clinical Recomendations for diagnosis, treatment and follow-up. Ann. Oncol. 2009, 20 (supl. 4), 110-112.
• Vitale G., Salvioli S., Franceschi C.: Oxidative stress and the ageing endocrine system. Nat. Rev. Endocrinol. 2013, 9, 228-240.
• Wójcik C., Wójcik M.: Niebiałkowe inhibitory kinaz zależnych od cyklin. Post. Biol. Kom. 2000, 27, 377-388.
• Youm Y. H., Grant R. W., McCabe I. R.: Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 2013, 18, 519-532.
• Zhang G., Li J., Purkayastha S.: Hypothalamus programming of systemic ageing involving IKK-beta, NFkB and GnRH. Nature 2013, 497, 211-216.
• Zucca E., Dreling M.: Gastric marginal zone lymphoma of MALT type: ESMO Clinical Recomendations for diagnosis, treatment and follow-up. Ann. Oncol. 2009, 20 (supl. 4), 113-114.

Identyfikatory

DOI

10.21521/mw.6164